Market Overview

Morning Market Movers

Related OMED
OncoMed Begins Patient Dosing In Phase 2 Clinical Trial Of Tarextumab In Small Cell Lung Cancer
OncoMed Pharma Offers Data from New Clinical, Biomarker Trial from Tarextumab, Demcizumab
Related CELG
#PreMarket Movers From December 19, 2014: NQ Mobile, BlackBerry, CarMax And More
#PreMarket Primer: Monday, December 15: Hostages Taken In Downtown Sydney
Yellen Swats Down Biotech, Social Media Stocks (Fox Business)

OncoMed Pharmaceuticals (NASDAQ: OMED) rose 67.14% to $23.40 on a deal to sell 1.47 million shares to Celgene (NASDAQ: CELG) at $15.13 per share.

EnteroMedics (NASDAQ: ETRM) moved up 31.39% to $1.80 after the company announced 18 month ReCharge study results.

Conatus Pharmaceuticals (NASDAQ: CNAT) jumped 26.22% to $7.75 as the company confirmed the FDA Orphan Drug Designation for emricasan for treatment of liver transplant recipients with reestablished fibrosis.

Unilife (NASDAQ: UNIS) shares jumped 15.90% to $4.81 after the company announced clinical supply agreement with Novartis (NYSE: NVS) for delivery of a novel drug.

Posted-In: market moversNews Intraday Update Markets Movers

 

Related Articles (CELG + CNAT)

Around the Web, We're Loving...

Get Benzinga's Newsletters